Topic: Health and Medicine
Dr. Moira Gunn talks with sleep experts, Bernard Pécoul Executive Director at DNDi and Yves Ribeill, CEO for Scynexis, about their work and the development of a drug for sleeping sickness.
Dr. Moira Gunn talks with author and geneticist, Bryan Sykes from Oxford University about his working combining history, science, and experience of what it means to be an American.
Dr. Moria Gunn talks about the trend of building a global medical team in order to make better health care decisions with IDBS' Vice President of Corporate Development, Chris Molloy.
What good is new energy technology if it can't be transported to the regions where it is most needed? In this audio interview, Sheela Sethuraman talks with Laura Stachel and Hal Aronson, co-founders of WE CARE Solar, about the international journey that led them to create one of the world's most portable solar energy systems. As The Tech Awards 2011 laureates of the Nokia Health Award, these two innovators work to bring reliable power to health care facilities all over the world.
Dr. Moira Gunn talks about nano-capsules, 100 times smaller than a blood cell, and their uses in a unique drug delivery system for cancer with the CEO of Epitarget, Esben Nilssen.
Dr. Moira Gunn learns about how the landscape of medicine is being changed by new discoveries in biology and genetics from Eric Topol, author of The Creative Destruction of Medicine: How the Digital Revolution Will Create Better Healthcare.
Dr. Moira Gunn talks about how intellectual property rights in the age of personalized medicine with head of the Life Sciences Practice at Baker Botts, Jen Gordon.
Dr. Moira Gunn discusses generic drugs in the biotech space called biosimilars with Group Commercial Director for Eden BioDesign, Roger Lias.
Dr. Moira Gunn talks with Director Orin Levine from The International Vaccine Access Center at Johns-Hopkins School of Medicine about The Gavi Alliance and vaccines for the poor.
Dr. Moira Gunn talks about an exciting breakthrough in the treatment of trauma to the brain with the President and CEO of Edge Therapeutics, Brian Leuthner.
